Matching slides 18,554
Current window 7,141-7,170
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all

Component

7,141-7,170 of 18,554

filter-aware
25
Uses a 'villain' narrative to undermine the credibility of the current CEO by linking him to a past corporate scandal.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
41
The slide uses a combination of analyst commentary and a direct testimonial to frame the company as a 'one-trick pony' in decline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Struggle2 hits
59
The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction2 hits
74
Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
75
The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
102
The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
132
Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
133
Uses CEO quote to undermine management credibility.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
153
Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
172
Uses a direct quote from a KOL to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
192
Includes a direct testimonial quote highlighted in yellow.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
206
Includes a direct testimonial from a high-volume implanter to support the thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
212
Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
239
The slide uses a direct quote from a KOL to support the thesis that Nevro reps are overstepping their professional boundaries.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
17
The slide uses a testimonial to establish credibility for the critique and links the founder to questionable research (algae electricity) to undermine his reputation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
18
Uses a 'villain' framing by comparing the CEO to Elizabeth Holmes.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
19
Uses an analogy to frame the technical difficulty as an insurmountable or near-impossible engineering challenge.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment2 hits
21
Uses a quote from a 'leading solid-state battery researcher' to validate the calculation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment2 hits
25
Uses a quote from a 'leading solid-state expert' to cast doubt on the validity of the company's technical claims.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment2 hits
26
Uses a Q&A format to frame the expert's critique of the company's data presentation.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment2 hits
27
The slide uses a Q&A format to highlight a specific technical discrepancy in a battery performance chart.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment2 hits
31
Uses expert testimony and annotated diagrams from a previous company presentation to highlight technical inconsistencies.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
42
Uses direct quotes and Q&A format to build a case of distrust.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
43
Uses a Q&A format to highlight internal dissent.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits
58
The slide uses a direct quote from an expert to frame the company's claim as fraudulent.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology2 hits